Sign in
WithdrawnPhase 2

Chemo-embolization for Head and Neck Cancer

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 2
Starts
May 2027
Expected to end
May 2030
Type of study
Interventional
Treatments tested
  • Cisplatin
Record updated
27 April 2025
Why it stopped
No staff or funding to do the study.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 1. Provision of signed and dated informed consent form
  • 2.Stated willingness to comply with all study procedures and availability for the duration of the study
  • 3.Male or female, aged 18 or older
  • 4.Diagnosed with squamous cell carcinoma of the Head and Neck
  • 5.Ability to undergo chemo-embolization
  • 6.For females of reproductive potential: Negative pregnancy test at time of chemo-embolization
  • 7.Platinum-ineligible as determined by presence of CTS grade I nephropathy, neuropathy or otopathy, and/or ECOG 2+ performance status
  • 8.Plan to undergo standard of care radiation and chemo- and/or immunotherapy

Who cannot take part

  • 2. Treatment with a competing investigational drug or intervention trial that does not allow adjuvant chemo-embolization
  • 1. Medically unfit to undergo chemo-embolization

Where in United States

  • University of Alabama at BirminghamBirmingham, United States

About the trial

What the trial wants to find out

The study will evaluate whether adjuvant chemo-embolization increases progression free and/or overall survival relative to standard of care radiation and chemo- and/or immunotherapy in cisplatin-ineligible head and neck cancer patients with an acceptable morbidity rate.

The group in the trial

  • Chemo-embolizationTreatment being tested

    Intra-arterial Cisplatin suspension 150-300 mg is infused into the tumor pedicle(s)

    Treatment: Cisplatin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
27 April 2025